ChatGPTを活用して業務のAI化を進めています。プロンプトエンジニアリングの専門家です！と、名乗れるレベルではありませんが、かなり色々使いこなしてきています。この１年、病気で失われた能力は、別な能力を発達させる、進化することで生き残っていこうと思います。
<><><>
23/08/26
[HTML] Precision medicine advances in idiopathic pulmonary fibrosis
T Karampitsakos, BM Juan-Guardela, A Tzouvelekis… - eBioMedicine, 2023
… IPF and Progressive Pulmonary Fibrosis(PPF) and the trend towards lumping rather than splitting, diagnostic biomarkers might be the least pressing need with regards to IPF… to discriminate patients with IPF from patients with alternative …
- 特発性肺線維症における精密医療の進歩
[HTML] Lung function trajectories in patients with idiopathic pulmonary fibrosis
ML Neely, AS Hellkamp, S Bender, JL Todd… - Respiratory Research, 2023
… Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterised by decline in lung function. We … Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease (ILD) associated with …
- 特発性肺線維症患者における肺機能の軌跡
[HTML] Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy
K Kataoka, K Oda, H Takizawa, T Ogura, A Miyamoto… - Scientific Reports, 2023
… idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases, and its use should be encouraged where necessary. The clinical course and survival of patients with IPF … associated with prognosis, and causes of death in IPF patients after the …
- 酸素療法を導入した特発性肺線維症患者の予後因子を評価するためのコホート研究
Lung Transplant Outcomes for Idiopathic Pulmonary Fibrosis: Are We Improving?
S Anderson, PR dos Santos, B Langlais, M Campany… - The Annals of Thoracic …, 2023
… BACKGROUND: Following implementation of the Lung Allocation Score in 2005, idiopathicpulmonary fibrosis (IPF) emerged as the most … more recent outcomes among the IPFpopulation. METHODS: We analyzed LTs for the primary indication of …
- 特発性肺線維症の肺移植成績：改善しているか？
[HTML] Vitamin D and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study
T Lin, F Zhou, H Mao, Z Xie, Y Jin - BMC Pulmonary Medicine, 2023
… A prospective study of multiple small samples found that idiopathic pulmonary fibrosis (IPF) is often accompanied by a deficiency in Vitamin D … Therefore, our study aims to investigate the causal effect of serum 1,25-hydroxyvitamin D (25(OH)D) …
- ビタミン D と特発性肺線維症: 2 サンプルのメンデルランダム化研究
[PDF] Characterize the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis
Z Zhang, X Ma, J Bai, S Xia, Q Han, Q Luo - Rheumatology, 2023
… Mortality prediction in idiopathic pulmonaryfibrosis: evaluation of computer-based CT analysis with … CXCR4(+) cells are increased in lung tissue of patients with idiopathicpulmonary fibrosis. Respir … Idiopathicnonspecific interstitial pneumonia/fibrosis …
- 自己免疫特徴を伴う間質性肺炎の洗浄液および血清サイトカインプロファイルの特徴と、進行性線維症への影響
Optimization of an Allysine-Targeted PET Probe for Quantifying Fibrogenesis in a Mouse Model of Pulmonary Fibrosis
S Shuvaev, RS Knipe, M Drummond, NJ Rotile, I Ay… - Molecular Imaging and …, 2023
… Idiopathic pulmonary fibrosis (IPF) is a destructive lung disease with a poor prognosis, an … using a pre-clinical model of pulmonaryfibrosis, with potential for translation into clinical use to … an optimized PET probe to measure disease activity …
- 肺線維症のマウスモデルにおける線維形成を定量化するためのアリシン標的 PET プローブの最適化
A case of lung carcinoma with a unique biphasic feature: Implications for histogenesis of" fake mucoepidermoid carcinoma" developing in the peripheral lung.
E Kumagai, M Matsumura, I Kato, H Arai, T Suzuki… - Pathology International, 2023
… The patient was a 67-year-old male smoker with idiopathic pulmonary fibrosis (IPF). A subpleural tumor in the left lower lobe, embedded in … The tumor could be trans-differentiating from lepidic adenocarcinoma to MEC, possibly promoted by IPF-induced tissue …
- 独特の二相性特徴を持つ肺癌の症例：末梢肺で発生する「偽粘表皮癌」の組織形成への影響。
Targeting cellular senescence: A promising approach in respiratory diseases
M Sugimoto - Geriatrics & Gerontology International, 2023
… Notably, the combination of dasatinib and quercetin (D + Q) has shown positive results in clinical trials for the treatment of diabetic kidney disease and idiopathic pulmonary fibrosis(IPF). Another promising drug, UBX-1325, has demonstrated …
- 細胞老化の標的: 呼吸器疾患における有望なアプローチ
[HTML] The role of immunosuppressive myofibroblasts in the aging process and age-related diseases
A Salminen - Journal of Molecular Medicine, 2023
… [39] demonstrated that myofibroblasts obtained from mice with idiopathic pulmonaryfibrosis revealed an impaired capacity to undergo the … the heterogeneity of fibroblast population in aged tissues as well as in idiopathic …
- 老化過程および加齢関連疾患における免疫抑制性筋線維芽細胞の役割
23/08/23
[HTML] Individualised Exercise Training Enhances Antioxidant Buffering Capacity in Idiopathic Pulmonary Fibrosis
TJM Wallis, M Minnion, A Freeman, A Bates, JM Otto… - Antioxidants, 2023
… We investigated the effect of an individualised aerobic interval training programme on functional capacity and redox status in patients with idiopathic pulmonary fibrosis (IPF). At baseline, IPF patients displayed evidence of increased …
- 個別化された運動トレーニングは特発性肺線維症の抗酸化緩衝能力を強化します
[PDF] EFFICACY OF ANTIFIBROTICS ON SURVIVAL RATES IN SUBJECTS WITH IDIOPATHIC PULMONARY FIBROSIS
SH Kabir, S Chakraborty, K Chatterjee, MRA Lodhi
… Methods: The study assessed 606 subjects of idiopathic pulmonary fibrosis as confirmed by the … IPF (idiopathic pulmonary fibrosis) is a condition causing progressive fibrosing interstitial lung diseases having a poor prognosis. The majority …
- 特発性肺線維症患者の生存率に対する抗線維症の有効性
23/08/22
[PDF] Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single‐arm, open‐label …
D Jastrzębski, S Kostorz‐Nosal, D Galle… - Health Science Reports, 2023
Background and Aims Antifibrotic therapies reduce lung function decline in patients with idiopathic pulmonary fibrosis (IPF). This single‐arm, open‐label, nonrandomized study aimed to determine the influence of antifibrotic treatment on …
- 特発性肺線維症患者における1年間のピルフェニドン治療前後の期待、症状、生活の質：単群非盲検非ランダム化研究
Palliative care in COPD and ILD: a call for action
M Wijsenbeek, C Valenzuela, A Holland - European Respiratory Journal, 2023
… progressive pulmonary fibrosis, with, for instance, idiopathic pulmonary fibrosisaccounting … of COPD and ILD, especially those with pulmonary fibrosis. With their current management we … Clinical guidelines for the management of idiopathic …
- COPDおよびILDにおける緩和ケア：行動の呼びかけ
[PDF] Gymnotic Uptake of AntimiRs Alter MicroRNA-34a Levels in 2D and 3D epithelial cell culture.
J Weidner, E Kolosionek, R Holmila, E Ax, M Garreau… - Molecular Therapy-Nucleic …, 2023
… MicroRNAs are attractive therapeutic targets in many diseases, including chronic obstructive 17 pulmonary disease and idiopathicpulmonary fibrosis. Among microRNA inhibitors antimiRs 18 have been proven successful in lowering aberrant …
- AntimiR の体操による取り込みにより、2D および 3D 上皮細胞培養における MicroRNA-34a レベルが変化します。
Survival and Soluble Immune Mediators of Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease in Patients with Non-Small Cell Lung Cancer
D Murata, K Azuma, K Murotani, N Matsuo, G Matama… - Lung Cancer
Background Immune checkpoint inhibitor-related interstitial lung disease (ICI-ILD) is a serious adverse event frequently observed in patients with non-small cell lung cancer (NSCLC). We investigated the clinical effects and mechanism of action of ICI-ILD …
- 非小細胞肺がん患者における免疫チェックポイント阻害剤誘発性間質性肺疾患の生存免疫メディエーターと可溶性免疫メディエーター
<><><>
特発性肺線維症( idiopathic pulmonary fibrosis (IPF) )関連の学術的情報収集してシェアしています。Google Scholar SearchのUpdateを定期的に掲載しています。GoogleのAIが一定の重み付けはしているとは思いますが、玉石混交です。
当面、毎週アラートの内容をアップしていこうと思います。
###
